Cancer Biopsy Market was valued at USD 5.02 Billion in 2022 and is projected to reach USD 8.50 Billion by 2030, growing at a CAGR of 7.20% from 2024 to 2030.
The cancer biopsy market has undergone significant transformations from 2018 to 2022, driven by advances in diagnostic technologies, growing cancer prevalence, and increasing awareness of early detection. During this period, the market witnessed a steady demand for traditional biopsy procedures, including core needle and fine-needle aspiration biopsies, particularly in oncology diagnostics. Innovations in liquid biopsy, driven by breakthroughs in molecular diagnostics, emerged as a significant contributor to the market growth. These non-invasive techniques provided quicker, more accurate ways to identify genetic mutations and other tumor markers, boosting the global biopsy market demand during this time. According to industry reports, the market for cancer biopsy procedures reached a substantial value in 2022, with growth predicted to continue in the near future.
However, when comparing this historical growth to projections from 2023 to 2033, the demand for cancer biopsy procedures is expected to shift notably. The next decade will likely see a rise in demand for minimally invasive biopsies, which can be attributed to technological advancements in imaging and robotic surgery. The integration of AI in diagnostic imaging, enabling higher precision in identifying abnormalities, will increase biopsy accuracy while reducing procedure risks. Liquid biopsy technologies are projected to dominate, offering advantages in monitoring cancer progression without the need for surgical intervention. Furthermore, the increasing number of personalized treatment regimens, coupled with the growing focus on precision medicine, will drive the cancer biopsy market forward. Emerging biomarkers and the increasing adoption of molecular profiling will propel liquid biopsy's share in the market, with companies exploring novel diagnostic platforms and tests to enhance patient outcomes.
Get an In-Depth Research Analysis of the Global Cancer Biopsy Market Size And Forecast [2025-2032]
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Cancer Biopsy Market
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Based on Types the Market is categorized into Below types that held the largest Cancer Biopsy market share In 2023.
Tissue Biopsies
Liquid Biopsies
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cancer Biopsy Market Research Analysis
1. Introduction of the Global Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Cancer Biopsy Market, By Type
6. Global Cancer Biopsy Market, By Application
7. Global Cancer Biopsy Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/